UNIVERSITATSKLINIKUM ERLANGEN - DE 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:500-600
Total Number of Projects:700-800
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 26
As coordinator: 3
As participant: 19
Sole participant: 4
Coordinator / Participant Ratio: 0.16*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 2.008.062 22.149.561 2.999.125 1 2
2020 2.986.937 22.287.978 4.406.771 2 4
2019 16.359.527 42.879.570 5.706.052 2 4
2018 0 3.000.000 103.750 1
2017 171.461 9.928.915 1.134.894 1 2
2016 0 21.666.437 778.722 3
2015 1.479.781 24.868.647 2.255.615 1 3

Networking:

Partners:

Institution:Projects [No]:
PFIZER LIMITED5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG4
KAROLINSKA INSTITUTE4
NOVARTIS PHARMA4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
KING'S COLLEGE LONDON3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSITY COLLEGE DUBLIN3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF NEWCASTLE UPON TYNE3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AMGEN LIMITED2
ASTELLAS PHARMA EUROPE BV2
ASTRAZENECA2
BAYER PHARMA2
BRISTOLMYERS SQUIBB COMPANY CORP2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
F HOFFMANNLA ROCHE2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
HOSPITAL CLINIC DE BARCELONA2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT GUSTAVE ROUSSY2
JANSSEN PHARMACEUTICA NV2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
LUDWIG BOLTZMANN GESELLSCHAFT2
LVIVSKYI NATIONALNYI MEDYCHNYI UNIVERSYTET IMENI DANYLA HALYTSKOHO2
MEDIZINISCHE UNIVERSITAET WIEN2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU2
NOVO NORDISK2
OSPEDALE PEDIATRICO BAMBINO GESU2
REDOXIS AB2
SANOFIAVENTIS2
SANOFIAVENTIS DEUTSCHLAND2
STICHTING KATHOLIEKE UNIVERSITEIT2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
UCB BIOPHARMA2
UNIVERSITAET BERN2
UNIVERSITAET ZUERICH2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF AARHUS2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF CAMBRIDGE2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF SURREY2
UPPSALA UNIVERSITET2
VIB VZW2
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL1
ABBVIE1
ABBVIE INC1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACTELION PHARMACEUTICALS1
ALGOE1
ANOCCA AB1
APITOPE INTERNATIONAL NV1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTON UNIVERSITY1
ASTRAZENECA AB1
ATHENA RESEARCH AND INNOVATION CENTER IN INFORMATION COMMUNICATION & KNOWLEGDE TECHNOLOGIES1
ATTUROS LIMITED1
AYUNTAMIENTO DE ASPARRENA1
BALKANIKA ENERGY AD1
BAYER1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIONTECH RNA PHARMACEUTICALS1
BOC ASSET MANAGEMENT1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BOWEL RESEARCH UK1
BULGARIAN ASSOCIATION FOR PERSONALIZED MEDICINE1
BULGARIAN ASSOCIATION FOR PROMOTION OF EDUCATION AND SCIENCE1
BUNDESMINISTERIUM FUER WIRTSCHAFT FAMILIE UND JUGEND1
CELLPHENOMICS1
CENTRE DE REGULACIO GENOMICA1
CENTRE HOSPITALIER DE L'UNIVERSITEDE MONTREAL1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III1
CHALMERS UNIVERSITY OF TECHNOLOGY1
CHARLES UNIVERSITY PRAGUE1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
CHU HOPITAUX DE BORDEAUX1
COCHLEAR RESEARCH AND DEVELOPMENT LIMITED1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CONSORZIO FUTURO IN RICERCA1
COPENHAGEN BUSINESS SCHOOL1
COVENTRY UNIVERSITY1
CSL BEHRING1
DANMARKS TEKNISKE UNIVERSITET1

Constancy:

Total number of partners: 348
Partner loyalty:
Frequent Partner: (> 2 projects): 45
Rare Partner: 303
Frequent / Rare Partner Ratio: 0.15

Project overview:

Start dateProjectacronymrolefundingpartners
2021-10-01Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies SCREEN4CAREparticipant11.938.56935
2021-07-01Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States HIPPOCRATESparticipant10.210.99327
2021-06-01Unknown functions of Osteocyte DEath ODEcoordinator2.008.0621
2020-12-01Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. HYPERBOOSTparticipant3.761.88211
2020-09-01Anchored Muscle cELls for IncontinencE AMELIEparticipant9.526.09713
2020-03-01Transcriptional and epigenetic control of tissue regenerative HB-EGF in autoimmune CNS inflammation H I C Icoordinator1.499.7062
2020-01-01RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. RESCUERparticipant6.000.00016
2020-01-01Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. NeutroCureparticipant2.999.99910
2020-01-01Breaking the barrier: How inflammation spreads from skin to joint BARRIER BREAKcoordinator1.487.2311
2019-10-01PancREatic Cancer OrganoiDs rEsearch Network PRECODEcoordinator3.992.89215
2019-07-01The role of protein degradation in FBXO11-related intellectual disability Degradation_IDparticipant174.8062
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-04-01Advancing osteoporosis medicine by observing bone microstructure and remodelling using a four-dimensional nanoscope 4-D nanoSCOPEcoordinator12.366.6354
2019-01-01Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. ONCOBIOMEparticipant14.994.55118
2019-01-01Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities EUPHORIAparticipant2.314.3155
2018-01-01Infradev - European Paediatric Translational Research Infrastructure ID-EPTRIparticipant3.000.00029
2017-11-01Research School for TINnitus Assessment, Causes and Treatments TIN-ACTparticipant3.928.91515
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-02-01The Viral Genome Associated Proteome VGAPcoordinator171.4611
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-01-01Pathogen and Graphene PANGparticipant580.5009
2015-11-01European AIDS Vaccine Initiative 2020 EAVI2020participant22.948.02226
2015-07-01Reactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils. REDOXITparticipant144.0004
2015-05-01Sorting of Self SOScoordinator1.479.7811
2015-03-01ORganizational Behaviour improvement for Energy Efficient adminisTrative public offices OrbEEtparticipant1.776.62510